Feature | April 30, 2007 | Cristen C. Bolan

Vital Signs 2.0 - Nuclear Medicine at the Bedside

The term “2.0” has become the catch phrase for all things next-gen. But is it just meaningless marketing jargon or new conventional wisdom? Or might it simply represent a logical stream of consciousness – making the obvious connections and then harnessing collective intelligence?
If you peruse Web developer O’Reilly Network’s site (www.oreillynet.com), it compares the transition from Web 1.0 to 2.0 to the paradigm leap that transitioned DoubleClick to Google AdSense, personal Web Sites to blogs and content management systems to wikis.
Similarly, medical imaging is poised to take its own rational leap by leveraging the powers of bioinformatics. When I asked SNM 2006-2007 President Martin P. Sandler, M.D., what he thought would be the most significant advancements in nuclear medicine over the next five years, his response bridged the perceived gap between biology and IT – the one which separates conferences like SNM and SIIM.
Dr. Sandler said that while there will be significant advances in translational imaging systems to speed up drug development and nanoparticle technology, he firmly stated, “I think quantification is the next big breakthrough in imaging technology.”
He referred to the use of quantitative analysis in clinical practice, providing medical specialists with hard facts to back visual findings and plan treatments. Dr. Sandler noted that, “in cardiac imaging, for example, these types of tools will allow us to quantify absolute bloodflow.” Which leads us to the next logical step – bringing nuclear medicine bedside.
By employing computational power, nuclear medicine will drive personalized medicine, looking at cell activities and developing specific imaging and therapeutic interventions tailored for individuals. “I think that the biggest advancement will be bringing quantitative measurements to the bedside,” said Dr. Sandler. Could this mean Nuclear Medicine 2.0?

Related Content

Novel PET Tracer Clearly Identifies and Tracks Bacterial Lung Infection

Representative PET/CT images of 18F-FDS and 18F-FDG in inflamed mice. Mice were inoculated with dead K. pneumoniae (10^8 CFU/mL). Imaging was performed for days 1, 2, 3 and 4 using 18F-FDG and 18F-FDS. CT images showed clear inflammation on day 2 and day 3 with corresponding high 18F-FDG uptake on PET. No significant uptake of 18F-FDS was detected for any of those 4 days. Credit: J Li et al., University of Louisville School of Medicine, Louisville, Ky.

News | PET-CT | January 22, 2018
January 22, 2018 — Researchers at the University of Louisville, Kentucky, have demonstrated that a new...
PET Tracer Gauges Effectiveness of Promising Alzheimer's Treatment

Longitudinal PET imaging with 18F-AV45. PET imaging shows the average 18F-AV45 uptake per animal group at 8 and 13 months of age. A significant interaction of genotype treatment was observed in the cortex (p = 0.0248), hippocampus (p = 0.0071) and thalamus (p = 0.0084), indicating reduced [18F]-AV45 uptake in BACE1 inhibited transgenic mice. Credit: MICA, University of Antwerp, Belgium.

News | Radiopharmaceuticals and Tracers | December 28, 2017
In the December featured basic science article in The Journal of Nuclear Medicine, Belgian researchers report on the...
Vital Unveils Newest Vitrea Advanced Visualization Release at RSNA 2017
Technology | Advanced Visualization | December 04, 2017
Vital Images unveiled the newest version of Vitrea Advanced Visualization software, the cornerstone of its imaging...
Michael J. Fox Foundation and Tau Consortium Developing PET Tracers for Neurodegenerative Disease
News | Radiopharmaceuticals and Tracers | October 27, 2017
The Michael J. Fox Foundation for Parkinson's Research (MJFF) and the Tau Consortium announced a funding partnership to...
Netherlands Cancer Institute Exploring Molecular Imaging Technology for Prostate Cancer Surgery
News | Molecular Imaging | October 26, 2017
The Netherlands Cancer Institute (NKI) announced it has received funding from the Dutch Cancer Society (KWF...
SNMMI Publishes New FDG PET/CT Appropriate Use Criteria
News | PET-CT | October 25, 2017
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has published appropriate use criteria (AUC) for FDG PET/...
Biodex Unveils Atomlab 500 Dose Calibrator and Wipe Test Counter
Technology | Nuclear Imaging | October 19, 2017
Biodex Medical Systems announced the full release of the Atomlab Dose Calibrator and Wipe Test Counter to the market...
ASNC and ASE Team Up to Expand ImageGuide Registry
News | Cardiovascular Ultrasound | October 12, 2017
The American Society of Nuclear Cardiology (ASNC) and the American Society of Echocardiography (ASE) jointly announced...
MR Solutions Showcases Multimodality MRI Solutions on Two Continents
News | Magnetic Resonance Imaging (MRI) | October 11, 2017
October 11, 2017 — MR Solutions took their cryogen-free preclinical multimodality...
Majority of Recurrent Prostate Cancer Patients' Treatment Plan Changed Following Fluciclovine 18F PET/CT
News | Prostate Cancer | October 04, 2017
Blue Earth Diagnostics recently announced the results of a pre-planned interim analysis from an investigational...
Overlay Init